Online first
Original Article
Published online: 2024-04-08

open access

Page views 296
Article views/downloads 175
Get Citation

Connect on Social Media

Connect on Social Media

Heart failure with preserved ejection fraction: diagnostic value of HFA-PEFF score, H₂FPEF score, and the diastolic stress echocardiography

Andrzej Kubicius1, Zbigniew Gąsior2, Maciej Haberka2
Pubmed: 38587116

Abstract

Introduction: The aim of our study was to compare 3 diagnostic pathways: diastolic stress echocardiography (DSE) based on the ASE/EACVI 2016 guidelines, the 2018 H₂FPEF score, and the 2019 HFA-PEFF algorithm, in patients suspected of heart failure with preserved ejection fraction (HFpEF).

Material and methods: The study group included 80 consecutive patients with a clinical suspicion of HFpEF. The H₂FPEF and HFA-PEFF scores and serum NT-proBNP concentrations were assessed in all the patients before they were sent for DSE.

Results: The DSE-based pathway confirmed HFpEF in 17 (21%) patients, the HFA-PEFF algorithm in 43 (54%), and H₂FPEF scoring in 4 (5%) patients. The ROC analysis showed that HFA-PEFF score > 5 predicts a DSE-positive test with a sensitivity of 70.5% and a specificity of 65%, (AUC = 0.711, p = 0.002) with a negative predictive value of 89.1% and positive predictive value of 35.3%. The H₂FPEF score > 3 had a negative predictive value of 90%, a positive predictive value of 29.8%, and predicted positive DSE result with a sensitivity of 82.3% but rather poor specificity of 47.6% (AUC = 0.692, p = 0.004). Both H₂FPEF and HFA-PEFF showed similar predictive values (AUC) in the prediction of positive DSE test (p = ns).  

Conclusions: The HFA-PEFF score overestimated the rate of HFpEF in comparison to DSE and the H₂FPEF score. The H₂FPEF and HFA-PEFF scores showed only modest predictive values of the positive DSE and had a diagnostic power to rule out the HFpEF.

Article available in PDF format

View PDF Download PDF file

References

  1. Owan TE, Hodge DO, Herges RM, et al. Trends in prevalence and outcome of heart failure with preserved ejection fraction. N Engl J Med. 2006; 355(3): 251–259.
  2. Pfeffer MA, Shah AM, Borlaug BA. Heart Failure With Preserved Ejection Fraction In Perspective. Circ Res. 2019; 124(11): 1598–1617.
  3. Borlaug BA. Evaluation and management of heart failure with preserved ejection fraction. Nat Rev Cardiol. 2020; 17(9): 559–573.
  4. Hoffman P. How to diagnose? How to treat? Dilemmas of the HFpEF. Cardiol J. 2020; 27(5): 469–471.
  5. McDonagh TA, Metra M, Adamo M, et al. ESC Scientific Document Group. 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure. Eur Heart J. 2021; 42(36): 3599–3726.
  6. Packer M, Butler J, Zannad F, et al. Effect of Empagliflozin on Worsening Heart Failure Events in Patients With Heart Failure and Preserved Ejection Fraction: EMPEROR-Preserved Trial. Circulation. 2021; 144(16): 1284–1294.
  7. Solomon SD, McMurray JJV, Claggett B, et al. DELIVER Trial Committees and Investigators. Dapagliflozin in Heart Failure with Mildly Reduced or Preserved Ejection Fraction. N Engl J Med. 2022; 387(12): 1089–1098.
  8. Ponikowski P, Voors AA, Anker SD, et al. ESC Scientific Document Group. 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC)Developed with the special contribution of the Heart Failure Association (HFA) of the ESC. Eur Heart J. 2016; 37(27): 2129–2200.
  9. Yancy CW, Jessup M, Bozkurt B, et al. WRITING COMMITTEE MEMBERS, American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. 2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines. Circulation. 2013; 128(16): e240–e327.
  10. Nagueh SF, Smiseth OA, Appleton CP, et al. Recommendations for the Evaluation of Left Ventricular Diastolic Function by Echocardiography: An Update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. J Am Soc Echocardiogr. 2016; 29(4): 277–314.
  11. Pieske B, Tschöpe C, de Boer RA, et al. How to diagnose heart failure with preserved ejection fraction: the HFA-PEFF diagnostic algorithm: a consensus recommendation from the Heart Failure Association (HFA) of the European Society of Cardiology (ESC). Eur Heart J. 2019; 40(40): 3297–3317.
  12. Kapłon-Cieślicka A, Kupczyńska K, Dobrowolski P, et al. On the search for the right definition of heart failure with preserved ejection fraction. Cardiol J. 2020; 27(5): 449–468.
  13. Reddy YNV, Carter RE, Obokata M, et al. A Simple, Evidence-Based Approach to Help Guide Diagnosis of Heart Failure With Preserved Ejection Fraction. Circulation. 2018; 138(9): 861–870.
  14. Mitchell C, Rahko PS, Blauwet LA, et al. Guidelines for Performing a Comprehensive Transthoracic Echocardiographic Examination in Adults: Recommendations from the American Society of Echocardiography. J Am Soc Echocardiogr. 2019; 32(1): 1–64.
  15. Pellikka PA, Arruda-Olson A, Chaudhry FA, et al. Guidelines for Performance, Interpretation, and Application of Stress Echocardiography in Ischemic Heart Disease: From the American Society of Echocardiography. J Am Soc Echocardiogr. 2020; 33(1): 1–41.e8.
  16. Amanai S, Harada T, Kagami K, et al. The HFPEF and HFA-PEFF algorithms for predicting exercise intolerance and abnormal hemodynamics in heart failure with preserved ejection fraction. Sci Rep. 2022; 12(1): 13.
  17. Nagueh SF. Diastology: 2020-A practical guide. Echocardiography. 2020; 37(11): 1919–1925.
  18. Sueta D, Yamamoto E, Nishihara T, et al. H2FPEF Score as a Prognostic Value in HFpEF Patients. Am J Hypertens. 2019; 32(11): 1082–1090.
  19. Hwang IC, Cho GY, Choi HM, et al. H2FPEF Score Reflects the Left Atrial Strain and Predicts Prognosis in Patients With Heart Failure With Preserved Ejection Fraction. J Card Fail. 2021; 27(2): 198–207.
  20. Sun Y, Si J, Li J, et al. Predictive Value of HFA-PEFF Score in Patients With Heart Failure With Preserved Ejection Fraction. Front Cardiovasc Med. 2021; 8: 656536.
  21. Gaggin HK, Januzzi JL. Biomarkers and diagnostics in heart failure. Biochim Biophys Acta. 2013; 1832(12): 2442–2450.
  22. Islam MN, Chowdhury MS, Paul GK, et al. Association of Diastolic Dysfunction with N-terminal Pro-B-type Natriuretic Peptide Level in Heart Failure Patients with Preserved Ejection Fraction. Mymensingh Med J. 2019; 28(2): 333–346.
  23. Grewal J, McKelvie R, Lonn E, et al. BNP and NT-proBNP predict echocardiographic severity of diastolic dysfunction. Eur J Heart Fail. 2008; 10(3): 252–259.
  24. Tschöpe C, Kasner M, Westermann D, et al. Elevated NT-ProBNP levels in patients with increased left ventricular filling pressure during exercise despite preserved systolic function. J Card Fail. 2005; 11(5 Suppl): S28–S33.
  25. Anjan VY, Loftus TM, Burke MA, et al. Prevalence, clinical phenotype, and outcomes associated with normal B-type natriuretic peptide levels in heart failure with preserved ejection fraction. Am J Cardiol. 2012; 110(6): 870–876.
  26. Buckley LF, Canada JM, Del Buono MG, et al. Low NT-proBNP levels in overweight and obese patients do not rule out a diagnosis of heart failure with preserved ejection fraction. ESC Heart Fail. 2018; 5(2): 372–378.
  27. Pritchett AM, Mahoney DW, Jacobsen SJ, et al. Diastolic dysfunction and left atrial volume: a population-based study. J Am Coll Cardiol. 2005; 45(1): 87–92.
  28. Melenovsky V, Hwang SJ, Redfield MM, et al. Left atrial remodeling and function in advanced heart failure with preserved or reduced ejection fraction. Circ Heart Fail. 2015; 8(2): 295–303.
  29. Almeida P, Rodrigues J, Lourenço P, et al. Left atrial volume index is critical for the diagnosis of heart failure with preserved ejection fraction. J Cardiovasc Med (Hagerstown). 2018; 19(6): 304–309.
  30. Barandiarán Aizpurua A, Sanders-van Wijk S, Brunner-La Rocca HP, et al. Validation of the HFA-PEFF score for the diagnosis of heart failure with preserved ejection fraction. Eur J Heart Fail. 2020; 22(3): 413–421.
  31. Kristensen SL, McMurray JJV. Diagnosing heart failure with preserved ejection fraction - what's the score? Eur J Heart Fail. 2020; 22(3): 425–427.
  32. Li S, Churchill T, Curreri L, et al. Diagnosing HFpEF: validation of a noninvasive diagnostic approach against invasive hemodynamics. Journal of the American College of Cardiology. 2020; 75(11): 911.
  33. Reddy YNV, Kaye DM, Handoko ML, et al. Diagnosis of Heart Failure With Preserved Ejection Fraction Among Patients With Unexplained Dyspnea. JAMA Cardiol. 2022; 7(9): 891–899.
  34. Takagi T. Diastolic stress echocardiography. J Echocardiogr. 2017; 15(3): 99–109.
  35. Prasad SB, Holland DJ, Atherton JJ. Diastolic stress echocardiography: from basic principles to clinical applications. Heart. 2018; 104(21): 1739–1748.
  36. Kim KH, Kane GC, Luong CL, et al. Echocardiographic Diastolic Stress Testing: What Does It Add? Curr Cardiol Rep. 2019; 21(9): 109.
  37. Nagueh SF, Sun H, Kopelen HA, et al. Hemodynamic determinants of the mitral annulus diastolic velocities by tissue Doppler. J Am Coll Cardiol. 2001; 37(1): 278–285.
  38. Obokata M, Kane GC, Reddy YNV, et al. Role of Diastolic Stress Testing in the Evaluation for Heart Failure With Preserved Ejection Fraction: A Simultaneous Invasive-Echocardiographic Study. Circulation. 2017; 135(9): 825–838.
  39. Sud K, Bhatia KS, Vogel B, et al. Prognostic significance of exercise-induced diastolic dysfunction: A systematic review. Echocardiography. 2020; 37(10): 1594–1602.
  40. Jong-Won H, Andersen OS, Simseth OA. Diastolic stress test. Invasive and noninvasive testing. JACC: Cardiovascular Imaging 2020;13(1):272-282.
  41. Fitzgerald BT, Presneill JJ, Scalia IG, et al. The Prognostic Value of the Diastolic Stress Test in Patients Undergoing Treadmill Stress Echocardiography. J Am Soc Echocardiogr. 2019; 32(10): 1298–1306.
  42. Gharacholou SM, Scott CG, Takahashi PY, et al. Left ventricular diastolic function and long-term outcomes in patients with normal exercise echocardiographic findings. Am J Cardiol. 2013; 112(2): 200–207.
  43. Mandoli GE, Sisti N, Mondillo S, et al. Left atrial strain in left ventricular diastolic dysfunction: have we finally found the missing piece of the puzzle? Heart Fail Rev. 2020; 25(3): 409–417.
  44. Smiseth OA, Donal E, Boe E, et al. Phenotyping heart failure by echocardiography: imaging of ventricular function and haemodynamics at rest and exercise. Eur Heart J Cardiovasc Imaging. 2023; 24(10): 1329–1342.